Home › Lung Cancer › NCT01585675

Specimen Banking From Patients With Lung Cancer

Who can join

Ages 18 to 85 · All sexes

Inclusion Criteria:

1. Subjects who are undergoing further testing for the diagnosis or treatment of lung cancer.
2. Oral and written informed consent

Exclusion Criteria:

1\. Any individual who does not give oral and written consent for participation

About the study

The primary objective of the protocol is to develop a comprehensive specimen banking program from patients with lung cancer for future translation research, which will enable the investigators to detect lung cancer earlier, develop better therapies and explore screening and prevention strategies.

Sponsor: University of Colorado, Denver · Participants: 2,000 · Started: Nov 3, 2005

Contact the study team

• Brandi Kubala · Phone: 303-724-1657

Official record on ClinicalTrials.gov — NCT01585675

Locations in the U.S.

Conditions

• Lung Cancer

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.